SOURCE-LINKED STUDY SUMMARY
Effects of pharmacological doses of nandrolone decanoate and progressive resistance training in immunodeficient patients infected with human immunodeficiency virus.
Abstract summarizedQuality not appraised
- What was studied
- An open-label randomized study compared nandrolone alone with nandrolone plus supervised resistance training for 12 weeks.
- Who / model studied
- Thirty men with HIV and reduced immune-cell counts participated. There was no placebo group.
- Studied dose & schedule
- Dose and schedule were not reported in the source used for this summary.
- What the study found
- Lean mass increased 3.9 kg with nandrolone alone and 5.2 kg with added training. Strength gains were greater with training. Body-cell mass and measured thigh-muscle areas increased in both groups without significant between-group differences for those measures.
- Limitations & context
- The study was explicitly open-label and lacked a placebo comparison, limiting attribution of within-group changes to nandrolone. The abstract does not report adverse-event results; these findings do not establish safety.
Read summary source ↗ · Prepared 9/22/2026 · AI-assisted, source-based summary
Review record & corrections
Summary prepared: . Source scope: abstract. This is an AI-assisted source summary, not an independent clinician sign-off.
No public field-by-field revision history is available for this card yet. The date above is the summary date, not proof that every field was updated then.
Inspect the source · Correction policyResearch findings apply to the population and conditions studied. This educational summary is not a treatment recommendation or a formal assessment of study quality.
Original publication ↗ · DOI: 10.1210/jcem.84.4.5610